Sai Lakshmi Subramanian

Sai Lakshmi Subramanian

Auto-generated profile, based on publicly available information

Sai Lakshmi Subramanian

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2013 in Nature
Verified
Journal Article
Open access
PDF file
SZSamir Zaidi
Samir Zaidi
MCMurim Choi
Murim Choi
HWHiroko Wakimoto
Hiroko Wakimoto
LMLijiang Ma
Lijiang Ma
JJJianming Jiang
Jianming Jiang
RLRichard P. Lifton
Richard P. Lifton
Exome sequencing of patients with congenital heart disease (CHD) and their unaffected parents reveals an excess of strong-effect, protein-altering de novo mutations in genes expressed in the developing heart, many of which regulate chromatin modification in key developmental genes; collectively, these mutations are predicted to account for approximately 10% of severe CHD cases. This paper demonstrates that de novo mutations with large effect have a role in the pathogenesis of at least 10% of cases of congenital heart disease (CHD). Using exome sequence analysis in parent–offspring trios Richard Lifton and colleagues compared the frequency of de novo mutations, identified by exome sequencing, in 362 CHD parent–offspring trios and 264 control trios. Gene ontology analysis demonstrated significant enrichment of de novo protein-altering mutation of genes involved in chromatin modification, notably a marked enrichment of genes involved in the production, removal and reading of methylation of histone H3K4 and H3K27. Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births1. Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent–offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation2,3,4. There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left–right organizer5. The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes ‘poised’ promoters and enhancers, which regulate expression of key developmental genes6. These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.

18 September 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SLS. Sai Lakshmi
S. Sai Lakshmi
SAShipra Agrawal
Shipra Agrawal
Piwi-interacting RNAs (piRNAs) are expressed in mammalian germline cells and have been identified as key players in germline development. These molecules, typically of length 25–33 nt, associate with Piwi proteins of the Argonaute family to form the Piwi-interacting RNA complex. These small regulatory RNAs have been implicated in spermatogenesis, repression of retrotransposon transposition in germline cells, epigenetic regulation and positive regulation of translation and mRNA stability. piRNABank is a highly user-friendly resource which stores empirically known sequences and other related information on piRNAs reported in human, mouse and rat. The database supports organism and chromosome-wise comprehensive search features including accession numbers, localization on chromosomes, gene name or symbol, sequence homology-based search, clusters and corresponding genes and repeat elements. It also displays each piRNA or piRNA cluster on a graphical genome-wide map ( http://pirnabank.ibab.ac.in/ ).

1 April 2019 in Cell
Verified
Journal Article
Closed access
OMOscar D. Murillo
Oscar D. Murillo
WTWilliam Thistlethwaite
William Thistlethwaite
JRJoel Rozowsky
Joel Rozowsky
SSSai Lakshmi Subramanian
Sai Lakshmi Subramanian
RLRocco Lucero
Rocco Lucero
AMAleksandar Milosavljevic
Aleksandar Milosavljevic

1 April 2019 in Cell Systems
Verified
Journal Article
Open access
JRJoel Rozowsky
Joel Rozowsky
RKRobert R. Kitchen
Robert R. Kitchen
JPJonathan J. Park
Jonathan J. Park
TGTimur R. Galeev
Timur R. Galeev
JDJames Diao
James Diao
MGMark Gerstein
Mark Gerstein
Small RNA sequencing has been widely adopted to study the diversity of extracellular RNAs (exRNAs) in biofluids; however, the analysis of exRNA samples can be challenging: they are vulnerable to contamination and artifacts from different isolation techniques, present in lower concentrations than cellular RNA, and occasionally of exogenous origin. To address these challenges, we present exceRpt, the exRNA-processing toolkit of the NIH Extracellular RNA Communication Consortium (ERCC). exceRpt is structured as a cascade of filters and quantifications prioritized based on one's confidence in a given set of annotated RNAs. It generates quality control reports and abundance estimates for RNA biotypes. It is also capable of characterizing mappings to exogenous genomes, which, in turn, can be used to generate phylogenetic trees. exceRpt has been used to uniformly process all ∼3,500 exRNA-seq datasets in the public exRNA Atlas and is available from genboree.org and github.gersteinlab.org/exceRpt.

1 September 2012 in Molecular Cell
Verified
Journal Article
Closed access
JXJordi Xiol
Jordi Xiol
ECElisa Cora
Elisa Cora
RKRubina Koglgruber
Rubina Koglgruber
SCShinichiro Chuma
Shinichiro Chuma
SSSailakshmi Subramanian
Sailakshmi Subramanian
RPRamesh S. Pillai
Ramesh S. Pillai

1 September 2012 in Molecular Cell
Verified
Journal Article
Open access
DODaniel Olivieri
Daniel Olivieri
KSKirsten-André Senti
Kirsten-André Senti
SSSailakshmi Subramanian
Sailakshmi Subramanian
RSRavi Sachidanandam
Ravi Sachidanandam
JBJulius Brennecke
Julius Brennecke
In animal gonads, PIWI proteins and their bound 23-30 nt piRNAs guard genome integrity by the sequence specific silencing of transposons. Two branches of piRNA biogenesis, namely primary processing and ping-pong amplification, have been proposed. Despite an overall conceptual understanding of piRNA biogenesis, identity and/or function of the involved players are largely unknown. Here, we demonstrate an essential role for the female sterility gene shutdown in piRNA biology. Shutdown, an evolutionarily conserved cochaperone collaborates with Hsp90 during piRNA biogenesis, potentially at the loading step of RNAs into PIWI proteins. We demonstrate that Shutdown is essential for both primary and secondary piRNA populations in Drosophila. An extension of our study to previously described piRNA pathway members revealed three distinct groups of biogenesis factors. Together with data on how PIWI proteins are wired into primary and secondary processing, we propose a unified model for piRNA biogenesis.